Skip to main content
SpringerLink
Log in

Non-Intensive Care Unit Management of Acute and Acute on Chronic Liver Failure

  • Chapter
  • First Online:
Liver Failure

Abstract

Acute liver failure (ALF) is defined by the occurrence of hepatic encephalopathy as the consequence of severe liver injury in a patient without pre-existing chronic liver disease, an exception being a fulminant presentation with hepatic encephalopathy of a patient with previously asymptomatic Wilson’s disease. ALF must be distinguished from acute on chronic liver failure (ACLF), a relatively recently described clinical entity in which an acute decompensation of chronic liver disease is accompanied by multi-organ failure and an high short-term mortality rate, mimicking that of ALF. An excessive systemic inflammatory response plays a crucial role in poor outcomes related to both of these liver failure syndromes. Close monitoring of organ function and support of failing organs, along with the identification and correction of the aetiology of the underlying liver insult and reversal of harmful systemic inflammation, are crucial if patient outcomes are to be optimised. This chapter focuses on the non-intensive care unit (ICU) management of these separate clinical entities of ALF and ACLF, including both aetiology-related and general supportive medical measures of proven value.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, editors. Progress in liver failure. New York: Grune and Stratton; 1970. p. 282–98.

    Google Scholar 

  2. O’Grady JG, Schalm S, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:373–5.

    Google Scholar 

  3. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;17:1644–55.

    Article  Google Scholar 

  4. O’Grady JG, Alexander GJM, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.

    Article  PubMed  Google Scholar 

  5. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376:190–201.

    Article  PubMed  Google Scholar 

  6. Hernaez R, Sola E, Moreau R, Gines P. Acute-on-chronic-liver failure: an update. Gut. 2017;66:541–3.

    Article  CAS  PubMed  Google Scholar 

  7. Claria J, Stauber R, Coenraad MJ, et al. Systemic inflammation in decompensated cirrhosis. Characterization and role in acute on chronic liver failure. Hepatology. 2016;64:1249–64.

    Article  CAS  PubMed  Google Scholar 

  8. Sole C, Sola E, Morales-Ruiz M, et al. Systemic inflammatory response profile in acute-on-chronic liver failure and its relationship with prognosis. Sci Rep. 2016;6:32341.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterilogy. 2013;144:1426–37.

    Article  Google Scholar 

  10. Shi Y, Yang Y, Hu Y, et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology. 2015;62:232–42.

    Article  PubMed  Google Scholar 

  11. Bernal W, Hyyrylainen A, Gera A, Audimoolan VK, McPhail MJ, Auzinger G, et al. Lessons from look-back in acute liver failure? A single Centre experience of 3300 patients. J Hepatol. 2013;59:74–80.

    Article  PubMed  Google Scholar 

  12. Germani G, Theocharidou E, Adam R, Karam V, Wendon J, O’Grady J, et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol. 2012;57:288–96.

    Article  PubMed  Google Scholar 

  13. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–81.

    Article  Google Scholar 

  14. O’Grady JG, Gimson AE, O’Brien CJ, et al. Controlled trials of charcoal haemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology. 1988;94:1186–92.

    Article  PubMed  Google Scholar 

  15. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg. 1999;5:29–34.

    Article  CAS  PubMed  Google Scholar 

  16. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis and applicability of prognostic criteria. Liver Transpl Surg. 2000;6:163–9.

    CAS  Google Scholar 

  17. Mutimer DJ, Ayres RCS, Neuberger JM, et al. Serious paracetamol poisoning and the results of liver transplantation. Gut. 1994;35:809–814.19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Makin A, Williams R. Paracetamol hepatotoxicity and alcohol consumption in deliberate and accidental overdose. Q J Med. 2000;93:341–9.

    Article  CAS  Google Scholar 

  19. Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987–1993). Gastroenterology. 1995;109:1907–16.

    Article  CAS  PubMed  Google Scholar 

  20. Lee WM. Acute liver failure. N Engl J Med. 1993;329:1862–72.

    Article  CAS  PubMed  Google Scholar 

  21. Pirotte JH. Apparent potentiation by phenobarbital of hepatotoxicity from small doses of acetaminophen (letter). Ann Int Med. 1984;101:403.

    Article  CAS  PubMed  Google Scholar 

  22. Wright N, Prescott LF. Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdose. Scott Med J. 1973;18:56–8.

    Article  CAS  Google Scholar 

  23. Emby DJ, Fraser BN. Hepatotoxicity of paracetamol enhanced by ingestion of alcohol. S Afr Med J. 1977;51:208–9.

    CAS  PubMed  Google Scholar 

  24. Eriksson LS, Broome U, Kalin M, Lindholm M. Hepatotoxicity due to repeated intake of low doses of paracetamol. J Intern Med. 1992;231:567–70.

    Article  CAS  PubMed  Google Scholar 

  25. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA. 1994;272:1845–50.

    Article  CAS  PubMed  Google Scholar 

  26. Harrison PM, Keays R, Bray GP, et al. Improved outcome in paracetamol-induced fulminant hepatic failure following late administration of acetylcysteine. Lancet. 1990;335:1572–3.

    Article  CAS  PubMed  Google Scholar 

  27. Williams R. Classification and clinical syndromes of acute liver failure. In: Lee WM, Williams R, editors. Acute liver failure. Cambridge: Cambridge University Press; 1997. p. 1–9.

    Google Scholar 

  28. Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10 year period. Gastroenterology. 2005;129:512–21.

    Article  PubMed  Google Scholar 

  29. Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a U.S. multicentre, prospective study. Hepatology. 2010;52:2065–76.

    Article  PubMed  Google Scholar 

  30. Devarbhavi H, Singh R, Patil M, Sheth K, Adarsh CK, Balaraju G. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury. J Gastroenterol Hepatol. 2013;28:161–7.

    Article  CAS  PubMed  Google Scholar 

  31. Wai CT, Tan BH, Chan CL, Sutedja DS, Lee YM, Khor C, et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int. 2007;27:465–74.

    Article  PubMed  Google Scholar 

  32. Riordan SM, Williams R. Liver disease due to illicit substance use. Addict Biol. 1998;3:47–53.

    Article  CAS  PubMed  Google Scholar 

  33. Sulkowski M, Thomas D, Chaisson R, et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B infection. JAMA. 2000;283:74–80.

    Article  CAS  PubMed  Google Scholar 

  34. Riordan SM, Kurtovic J, Williams R. Fulminant hepatic failure. In: Schiff E, Sorrell M, Madrey W, editors. Schiff’s diseases of the liver. 10th ed. New Jersey: Lippincott, Williams & Wilkins; 2007. p. 601–36.

    Google Scholar 

  35. Gruson D, Hilbert G, Le Bail B, et al. Fulminant hepatitis due to herpes simplex virus-type 2 in early phase of bone marrow transplantation. Hematol Cell Ther. 1998;40:41–4.

    CAS  PubMed  Google Scholar 

  36. Ajmera V, Xia G, Vaughan G, Forbi JC, Ganova-Raeva LM, Khudyakov Y, et al. What factors determine the severity of hepatitis A-related acute liver failure. J Viral Hepat. 2011;18:e167–74.

    Article  CAS  PubMed  Google Scholar 

  37. Taylor RM, Davern T, Munoz S, Han SH, McGuire B, Larson AM, et al. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology. 2006;44:1589–97.

    Article  CAS  PubMed  Google Scholar 

  38. Rezende G, Roque-Afonso AM, Samuel D, Gigou M, Nicand E, Ferre V, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology. 2003;38:613–8.

    Article  PubMed  Google Scholar 

  39. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338:286–90.

    Article  CAS  PubMed  Google Scholar 

  40. Bianco E, Stroffolini T, Spada E, Szklo A, Marzolini F, Ragni P, et al. Case fatality rate of acute viral hepatitis in Italy: 1995–2000. An update. Dig Liver Dis. 2003;35:404–8.

    Article  CAS  PubMed  Google Scholar 

  41. Manka P, Bechmann LP, Coombes JD, Thodou V, Schlattjan M, Kahraman A, et al. Hepatitis E virus infection as a possible cause of acute liver failure in Europe. Clin Gastroenterol Hepatol. 2015;13:1836–42.

    Article  PubMed  Google Scholar 

  42. Pande C, Sarin SK, Patra S, Bhutia K, Mishra SK, Pahuja S, et al. Prevalence, risk factors and virological profile of chronic hepatitis B virus infection in pregnant women in India. J Med Virol. 2011;83:962–7.

    Article  PubMed  Google Scholar 

  43. Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hepat. 2003;10:224–31.

    Article  CAS  PubMed  Google Scholar 

  44. Madan K, Gopalkrishna V, Kar P, Sharma JK, Das UP, Das BC. Detection of hepatitis C and E virus genomes in sera of patients with acute viral hepatitis and fulminant hepatitis by their simultaneous amplification in PCR. J Gastroenterol Hepatol. 1998;13:125–30.

    Article  CAS  PubMed  Google Scholar 

  45. Acharya SK, Dasarathy S, Kumer TS, Sushma S, Prasanna KS, Tandon A, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology. 1996;23:1448–55.

    Article  CAS  PubMed  Google Scholar 

  46. Jain A, Kar P, Madan K, Das UP, Budhiraja S, Gopalkrishna V, et al. Hepatitis C virus infection in sporadic fulminant viral hepatitis in North India: cause or co-factor ? Eur J Gastroenterol Hepatol. 1999;11:1231–7.

    Article  CAS  PubMed  Google Scholar 

  47. Bernuau J, Nicand E, Durand F. Hepatitis E-associated acute liver failure in pregnancy: an Indian puzzle. Hepatology. 2008;48:1380–2.

    Article  PubMed  Google Scholar 

  48. Shalimar, Acharya SK. Hepatitis E and acute liver failure in pregnancy. J Clin Exp Hepatol. 2013;3:213–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Borkakoti J, Hazam RK, Mohammad A, Kumar A, Kar P. Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy? J Med Virol. 2013;85:620–6.

    Article  CAS  PubMed  Google Scholar 

  50. Yanagi M, Kaneko S, Unoura M, Murakami S, Kobayashi K, Sugihara J, et al. Hepatitis C virus in fulminant hepatic failure. N Engl J Med. 1991;324:1895–6.

    Article  CAS  PubMed  Google Scholar 

  51. Toshiba M, Sekiyama K, Sugata F, Okamoto H. Diagnosis of type C fulminant hepatitis by the detection of antibodies to the putative core proteins of hepatitis C virus. Gastroenterol Jpn. 1991;26:234.

    Google Scholar 

  52. Chu C-M, Sheen I-S, Liaw Y-F. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology. 1994;107:189–95.

    Article  CAS  PubMed  Google Scholar 

  53. Tung J, Hadzic N, Layton M, et al. Bone marrow failure in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2000;31:557–61.

    Article  CAS  PubMed  Google Scholar 

  54. Dugan MJ, Rouch DA, Akard LP, et al. Successful allogeneic bone marrow transplantation in an adult with aplastic anaemia following orthotopic liver transplantation for non-A, non-B, non-C hepatitis. Bone Marrow Transplant. 1993;12:417–9.

    CAS  PubMed  Google Scholar 

  55. Trede NS, Warwick AB, Rosoff PM, et al. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anaemia following orthotopic liver transplantation. Bone Marrow Transplant. 1997;20:257–60.

    Article  CAS  PubMed  Google Scholar 

  56. Cattral MS, Langnas AN, Markin RS, et al. Aplastic anaemia after liver transplantation for fulminant liver failure. Hepatology. 1994;20:813–8.

    Article  CAS  PubMed  Google Scholar 

  57. Ichai P, Duclos-Vallee JC, Guettier C, Hamida SB, Antonini T, Delvart V, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl. 2007;13:996–1003.

    Article  PubMed  Google Scholar 

  58. Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY. Preeclampsia: an update. Acta Anaesthesiol Belg. 2014;65:137–49.

    CAS  PubMed  Google Scholar 

  59. Durand F, Bernuau J, Giostra E, et al. Wilson’s disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut. 2001;41:849–52.

    Article  Google Scholar 

  60. Matthews CE, Goonasekera C, Dhawan A, Deep A. Validity of pediatric index of mortality 2 (PIM2) score in pediatric acute liver failure. Crit Care. 2014;18:665.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Gores KM, Hamieh TS, Schmidt GA. Survival following investigational treatment of amanita mushroom poisoning: thistle or shamrock? Chest. 2014;146:e126–9.

    Article  PubMed  Google Scholar 

  62. Vanooteghem S, Arts J, Decock S, Pieraerts P, Meersseman W, Verslype C, et al. Four patients with Amanita Phalloides poisoning. Acta Gastroenterol Belg. 2014;77:353–6.

    CAS  PubMed  Google Scholar 

  63. Mahler H, Pasi A, Kramer JM, et al. Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N Engl J Med. 1997;336:1142–8.

    Article  CAS  PubMed  Google Scholar 

  64. Krag M, Perner A, Wetterslev J, Wise MP, Borthwick M, Bendel S, et al. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med. 2015;41:833–45.

    Article  CAS  PubMed  Google Scholar 

  65. Krag M, Perner A, Wetterslev J, Wise MP, Borthwick M, Bendel S, et al. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiol Scand. 2015;59:576–85.

    Article  CAS  PubMed  Google Scholar 

  66. Gordon D, Young LR, Reddy S, Bergman C, Young JD. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor. J Hosp Infect. 2016;92:173–7.

    Article  CAS  PubMed  Google Scholar 

  67. Walsh TS, Wigmore SJ, Hopton P, et al. Energy expenditure in acetaminophen-induced fulminant hepatic failure. Crit Care Med. 2000;28:649–54.

    Article  CAS  PubMed  Google Scholar 

  68. McCullough AJ, Tavill AS. Disordered protein and energy metabolism in liver disease. Semin Liv Dis. 1991;11:265–77.

    Article  CAS  Google Scholar 

  69. Fryburg DA, Barrett EJ. Insulin, growth hormone and IGF-1 regulation of protein metabolism. Diabetes Rev. 1995;3:93–112.

    Google Scholar 

  70. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology. 2002;36:659–65.

    Article  CAS  PubMed  Google Scholar 

  71. Plauth M, Merli M, Kondrup J, et al. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr. 1997;16:43–5.

    Article  CAS  PubMed  Google Scholar 

  72. Qiu JG, Delany HM, Teh EL, et al. Contrasting effects of identical nutrients given parenterally or enterally after 70% hepatectomy: bacterial translocation. Nutrition. 1997;13:473–4.

    Article  Google Scholar 

  73. Harvey SE, Parrott F, Harrison DA, Bear DE, Segaran E, Beale R, et al. Trial of the route of early nutritional support in critically ill adults. N Engl J Med. 2014;371:1673–84.

    Article  PubMed  CAS  Google Scholar 

  74. Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, et al. Early vs. late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365:506–17.

    Article  CAS  PubMed  Google Scholar 

  75. Langouche L, Vander Perre S, Marques M, Boelen A, Wouters PJ, Casaer MP, et al. Impact of early nutrient restriction during critical illness on the nonthyroidal illness syndrome and its relation with outcome: a randomized, controlled clinical study. J Clin Endocrinol Metab. 2013;98:1006–13.

    Article  CAS  PubMed  Google Scholar 

  76. O’Riordan A, Brummell Z, Sizer E, Auzinger G, Heaton N, O’Grady JG, et al. Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol Dial Transplant. 2011;26:3501–8.

    Article  PubMed  Google Scholar 

  77. Leithead JA, Ferguson JW, Bates CM, Davidson JS, Lee A, Bathgate AJ, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–9.

    Article  CAS  PubMed  Google Scholar 

  78. Davenport A. Is there a role for continuous renal replacement therapies in patients with liver and renal failure? Kidney Int Suppl. 1999;72:S62–6.

    Article  CAS  Google Scholar 

  79. Slowinski T, Morgera S, Joannidis M, Henneberg T, Stocker R, Helset E, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care. 2015;19:349.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Stravitz RT, Lisman T, Luketic VA, Sterling RK, Puri P, Fuchs M, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012;56:129–36.

    Article  PubMed  Google Scholar 

  81. Agarwal B, Gatt A, Riddell A, Wright G, Chowdary P, Jalan R, et al. Hemostasis in patients with acute kidney injury secondary to acute liver failure. Kidney Int. 2013;84:158–63.

    Article  CAS  PubMed  Google Scholar 

  82. Stravitz RT, Bowling R, Bradford RL, Key NS, Glover S, Thacker LR, et al. Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure. Hepatology. 2013;58:304–13.

    Article  CAS  PubMed  Google Scholar 

  83. Lelubre C, Vincent JL, Taccone FS. Red blood cell transfusion strategies in critically ill patients: lessons from recent randomized clinical studies. Minerva Anesthesiol. 2016;82:1010–6.

    Google Scholar 

  84. Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis. 1996;16:389–402.

    Article  CAS  PubMed  Google Scholar 

  85. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Casewell M, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. 1991;12:1–9.

    Article  CAS  PubMed  Google Scholar 

  86. Karvellas CJ, Pink F, McPhail M, Cross T, Auzinger G, Bernal W, et al. Predictors of bacteremia and mortality in patients with acute liver failure. Intensive Care Med. 2009;35:1390–6.

    Article  PubMed  Google Scholar 

  87. Karvellas CJ, Cavazos J, Battenhouse H, Durkalski V, Balko J, Sanders C, et al. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatolol. 2014;12:1942–9.

    Article  CAS  Google Scholar 

  88. Rolando N, Wade J, Davalos M, et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000;32:734–9.

    Article  CAS  PubMed  Google Scholar 

  89. Possamai LA, Antoniades CG, Anstee QM, Quaglia A, Vergani D, Thursz M, et al. Role of monocytes and macrophages in experimental and human acute liver failure. World J Gastroenterol. 2010;16:1811–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856–64.

    Article  CAS  PubMed  Google Scholar 

  91. Harrison P, Wendon J, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology. 1996;23:1067–72.

    Article  CAS  PubMed  Google Scholar 

  92. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med. 1991;324:1852–7.

    Article  CAS  PubMed  Google Scholar 

  93. Stravitz RT, Sanyal AJ, Reisch J, Bajaj JS, Mirshahi F, Cheng J, et al. Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival. Liver Int. 2013;33:1324–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Kim Do Y, Jun JH, Lee HL, Woo KM, Ryoo HM, Kim GS, et al. N-acetylcysteine prevents LPS-induced pro-inflammatory cytokines and MMP2 production in gingival fibroblasts. Arch Pharm Res. 2007;30:1283–92.

    Article  PubMed  Google Scholar 

  95. Serste T, Cornillie A, Njimi H, Pavesi M, Arroyo V, Putignano A, et al. The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis. J Hepatol. 2018;69:318–24.

    Article  PubMed  Google Scholar 

  96. Yang J, Chen G, Chen X, Zhang H, Jiang D, Yang G. Initial combination anti-viral therapy with lamivudine and adefofovir dipivoxil decreases short-term fatality rate of hepatitis B virus-related acute on chronic liver failure. Virol J. 2015;12:97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Gustot T, Moreau R. Acute-on-chronic liver failure vs traditional acute decompensation of cirrhosis. J Hepatol. 2018;69:1384–93.

    Article  PubMed  Google Scholar 

  98. Arora V, Maiwall R, Rajan V, Jindal A, Muralikrishna Shasthry S, Kumar G, et al. Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure. Hepatology. 2019;71:600–10.

    Article  PubMed  CAS  Google Scholar 

  99. Piano S, Schmidt HH, Ariza X, Amoros A, Romano A, Husing-Kabar A, et al. Association between grade of acute on chronic liver failure and response to Terlipressin and albumin in patients with hepatorenal syndrome. Clin Gastroenterol Hepatol. 2018;16:1792–800.

    Article  CAS  PubMed  Google Scholar 

  100. Mookerjee RP, Pavesi M, Thomsen KL, Mehta G, Macnaughtan J, Dendtsen F, et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic-liver failure. J Hepatol. 2016;64:574–82.

    Article  CAS  PubMed  Google Scholar 

  101. Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, et al. Granulocyrte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:505–12.

    Article  CAS  PubMed  Google Scholar 

  102. Duan XZ, Liu FF, Tong JJ, Yang HZ, Chen J, Liu XY, et al. Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol. 2013;19:1104–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Lin BL, Chen JF, Qiu WH, Wang KW, Xie DY, Chen XY, et al. Allogeneic bone-marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomised controlled trial. Hepatology. 2017;66:209–19.

    Article  CAS  PubMed  Google Scholar 

  104. Philips CA, Pande A, Shasthry SM, Jamwal KD, Khillan V, Chandel SS, et al. Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study. Clin Gastroenterol Hepatol. 2017;15:600–2.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastrointestinal and Liver Unit, Prince of Wales Hospital, Sydney, Australia

    Stephen M. Riordan

  2. Prince of Wales Clinical School, UNSW Medicine, University of New South Wales, Sydney, Australia

    Stephen M. Riordan

Authors
  1. Stephen M. Riordan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen M. Riordan .

Editor information

Editors and Affiliations

  1. Department of Medicine, Division of Gastroenterology and Hepatology, Rutgers University, New Jersey Medical School, Newark, NJ, USA

    Nikolaos Pyrsopoulos

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Riordan, S.M. (2020). Non-Intensive Care Unit Management of Acute and Acute on Chronic Liver Failure. In: Pyrsopoulos, N. (eds) Liver Failure. Springer, Cham. https://doi.org/10.1007/978-3-030-50983-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-50983-5_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-50982-8

  • Online ISBN: 978-3-030-50983-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation